Thursday, January 6, 2011

ImmunoCellular Therapeutics Receives FDA Approval To Commence Phase II Trial Of ICT-107

ImmunoCellular Therapeutics Receives FDA Approval To Commence Phase II Trial Of ICT-107:
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)